1. Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon.
- Author
-
Sundaragiri PR, Vallabhajosyula S, Haddad TM, and Esterbrooks DJ
- Subjects
- Adult, Anti-Bacterial Agents therapeutic use, Cephalosporins therapeutic use, Daptomycin therapeutic use, Drug Resistance, Multiple, Bacterial, Fatal Outcome, Humans, Male, Staphylococcal Infections complications, Vancomycin pharmacology, Ceftaroline, Endocarditis, Bacterial microbiology, Heart Valve Diseases microbiology, Methicillin-Resistant Staphylococcus aureus drug effects, Mitral Valve, Staphylococcal Infections drug therapy, Tricuspid Valve
- Abstract
Right-sided infective endocarditis (RIE) is commonly due to Staphylococcus aureus and often involves the tricuspid valve (TV). A 31-year-old man with prior intravenous drug use presented with substernal pain, cough, dyspnoea and fever. Examination revealed a febrile, tachycardic male with peripheral infective endocarditis stigmata and right-heart failure. Laboratory parameters demonstrated leucocytosis, lactic acidosis and methicillin-resistant S. aureus (MRSA) bacteraemia. Echocardiography demonstrated multiple TV echodensities and chest imaging confirmed septic emboli. The MRSA species demonstrated 'vancomycin-creep', necessitating therapy with daptomycin and ceftaroline. Owing to persistent bacteraemia and septic shock, the patient underwent TV surgery, but continued to have a poor postoperative course with subsequent death. Indications for surgical therapy of RIE are limited to the European guidelines and most data are extrapolated from left-heart disease. MRSA exhibiting vancomycin-creep portends a poorer prognosis and requires aggressive therapy. We advocate the use of ceftaroline salvage therapy with daptomycin, pending further trials., (2015 BMJ Publishing Group Ltd.)
- Published
- 2015
- Full Text
- View/download PDF